Encell Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Public

  • Employees
  • 104

Employees

  • Stock Symbol
  • 456070

Stock Symbol

  • Share Price
  • $10.31
  • (As of Thursday Closing)

Encell General Information

Description

ENCell Co Ltd is a biopharmaceutical company. The company is engaged in conducting biopharmaceutical contract development and manufacturing (CDMO) service business and cell, gene therapy new drug development business for rare/incurable muscle diseases such as Charcot-Marie-Tooth disease, Duchenne muscular dystrophy, and sarcopenia.

Contact Information

Website
www.encellinc.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 11th floor, 701 Yeongdong-daero
  • Gangnam-gu, Cheongdam-dong
  • Seoul
  • South Korea
+82
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Clinics/Outpatient Services
Stock Exchange
KRX
Vertical(s)
LOHAS & Wellness, HealthTech, Life Sciences
Corporate Office
  • 11th floor, 701 Yeongdong-daero
  • Gangnam-gu, Cheongdam-dong
  • Seoul
  • South Korea
+82

Encell Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Encell Stock Performance

As of 24-Apr-2025, Encell’s stock price is $10.31. Its current market cap is $110M with 10.7M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$10.31 $10.40 $8.31 - $34.14 $110M 10.7M 608K -$1.27

Encell Financials Summary

As of 31-Dec-2024, Encell has a trailing 12-month revenue of $5.28M.

In Thousands,
USD 		TTM 31-Dec-2024 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022
EV 107,861 107,861
Revenue 5,284 5,284 8,051 5,702
EBITDA (8,067) (8,067) 397 (31,034)
Net Income (11,147) (11,147) (3,865) (35,265)
Total Assets 37,845 37,845 34,129 43,349
Total Debt 3,497 3,497 3,428 3,917
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Encell Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Encell‘s full profile, request access.

Request a free trial

Encell Patents

  • 22

    Total Documents Applications and Grants

  • Total Patents Families

  • 4

    Granted

  • 17

    Pending

  • Expiring in next 12 mo

Encell Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4257703-A1 Method for selecting mesenchymal stem cells having improved self-maintenance ability, and mesenchymal stem cells selected thereby Pending 07-Dec-2020
US-20240018588-A1 Method for selecting mesenchymal stem cells having improved self-maintenance ability, and mesenchymal stem cells selected thereby Pending 07-Dec-2020
EP-4245307-A1 Composition for preventing or treating muscle diseases, containing stem cells in which gro-? is expressed or gro-? Inactive 13-Nov-2020
US-20230416684-A1 Composition for preventing or treating muscle diseases, containing stem cells in which gro-alpha is expressed or gro-alpha Pending 13-Nov-2020
AU-2021377668-A1 Early mesenchymal stem cells with reduced aging and preserved stem cell ability, and culturing method therefor Pending 11-Nov-2020 C12N5/0665
To view Encell’s complete patent history, request access »

Encell Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Encell FAQs

  • When was Encell founded?

    Encell was founded in 2018.

  • Where is Encell headquartered?

    Encell is headquartered in Seoul, South Korea.

  • What is the size of Encell?

    Encell has 104 total employees.

  • What industry is Encell in?

    Encell’s primary industry is Biotechnology.

  • Is Encell a private or public company?

    Encell is a Public company.

  • What is Encell’s stock symbol?

    The ticker symbol for Encell is 456070.

  • What is the current stock price of Encell?

    As of 24-Apr-2025 the stock price of Encell is $10.31.

  • What is the current market cap of Encell?

    The current market capitalization of Encell is $110M.

  • What is Encell’s current revenue?

    The trailing twelve month revenue for Encell is $5.28M.

  • What is Encell’s annual earnings per share (EPS)?

    Encell’s EPS for 12 months was -$1.27.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »